Q&A: The FDA's challenge in regulating evolving digital health tools | MobiHealthNews

Retrieved on: 2022-10-15 04:41:56

Tags for this article:

Food and Drug Administration

Health

Articles

Medical device

Office of In Vitro Diagnostics and Radiological Health

Validation

Criticism of the Food and Drug Administration

Title 21 CFR Part 11

Click the tags to see associated articles and topics

Q&A: The FDA's challenge in regulating evolving digital health tools | MobiHealthNews. View article details on hiswai:

Excerpt

"Based on these observations from the pilot, FDA has found that rapidly evolving technologies in the modern medical device landscape could benefit ...

Article found on: www.mobihealthnews.com

View Original Article